PlainRecalls
FDA Drug Low Class III Terminated

Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01

Reported: September 1, 2021 Initiated: August 5, 2021 #D-0771-2021

Product Description

Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01

Reason for Recall

Labeling: Not elsewhere classified: Mislabeling

Details

Units Affected
1,152 vials
Distribution
USA nationwide
Location
Cherry Hill, NJ

Frequently Asked Questions

What product was recalled?
Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01. Recalled by Hikma Pharmaceuticals USA Inc.. Units affected: 1,152 vials.
Why was this product recalled?
Labeling: Not elsewhere classified: Mislabeling
Which agency issued this recall?
This recall was issued by the FDA Drug on September 1, 2021. Severity: Low. Recall number: D-0771-2021.